APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hemostatic Forceps

Hemostatic Forceps (also called a Hemostat) is a surgical tool used in many surgical procedures to control bleeding or the flow of liquids in tubing. They have ring handles just like scissors. The ratcheted handles can be locked in multiple positions in order to maintain variable levels of constant pressure.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Hemostatic Forceps (also called a Hemostat) is a surgical tool used in many surgical procedures to control bleeding or the flow of liquids in tubing. They have ring handles just like scissors. The ratcheted handles can be locked in multiple positions in order to maintain variable levels of constant pressure.

For different application, there are generally three types of hemostatic forceps, which include Halstead mosquito hemostatic forceps, Kelly and Crile hemostatic forceps and Rochester-Carmalt hemostatic forceps.

Selected research

Market Outlook & Growth Opportunities

Global Hemostatic Forceps Market Outlook and Growth Opportunities 2026

23 December 2025218 pages

Choose your research edition.

Industry ResearchHemostatic Forceps Industry Research Report 2026150 pages · $2,950 USDIndustry Growth & TrendsGlobal Hemostatic Forceps Industry Growth and Trends Forecast to 2032128 pages · $3,450 USDMarket StructureGlobal Hemostatic Forceps Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hemostatic Forceps Market Outlook and Growth Opportunities 2026218 pages · $4,250 USDMarket Analysis & ForecastGlobal Hemostatic Forceps Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

Hemostatic Forceps (also called a Hemostat) is a surgical tool used in many surgical procedures to control bleeding or the flow of liquids in tubing. They have ring handles just like scissors. The ratcheted handles can be locked in multiple positions in order to maintain variable levels of constant pressure.

For different application, there are generally three types of hemostatic forceps, which include Halstead mosquito hemostatic forceps, Kelly and Crile hemostatic forceps and Rochester-Carmalt hemostatic forceps.

Global Hemostatic Forceps key players include Medline, B. Braun, CareFusion, Sklar, Scanlan International, etc. Global top five manufacturers hold a share over 45%.

Read the full market overview

North America is the largest market, with a share over 30%, followed by Europe and China, both have a share about 45%.

In terms of product, Halstead Mosquito Hemostatic Forceps is the largest segment, with a share over 55%.

This report provides an overview of the global Hemostatic Forceps market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Hemostatic Forceps and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Hemostatic Forceps sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Hemostatic Forceps market size, projected growth trends, production technologies, key applications, and end-use industries.

Hemostatic Forceps Segment by Company

Medline

B. Braun

CareFusion

Asa Dental

Sklar

Scanlan International

Shanghai Medical Instruments

Lawton

Hu-Friedy

Xinhua Surgical

Towne Brothers

Teleflex Medical

Delacroix Chevalier

YDM

M A Corporation

MedGyn Products

Inami

Ted Pella

Medicon eG

J & J Instruments

American Diagnostic

Hemostatic Forceps Segment by Type

Halstead Mosquito Hemostatic Forceps

Kelly and Crile Hemostatic Forceps

Rochester-Carmalt Hemostatic Forceps

Hemostatic Forceps Segment by Application

Surgical

Dissection

Dental

Laparoscopic

Others

Hemostatic Forceps Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Hemostatic Forceps status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Hemostatic Forceps market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Hemostatic Forceps significant trends, drivers, influence factors in global and regions.

6. To analyze Hemostatic Forceps competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hemostatic Forceps market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hemostatic Forceps and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hemostatic Forceps.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Hemostatic Forceps market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Hemostatic Forceps industry.

Chapter 3: Detailed analysis of Hemostatic Forceps manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Hemostatic Forceps in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Hemostatic Forceps in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Hemostatic Forceps Industry Trends Table 2. Hemostatic Forceps Industry Drivers Table 3. Hemostatic Forceps Industry Opportunities and Challenges Table 4. Hemostatic Forceps Industry Restraints Table 5. Global Hemostatic Forceps Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Hemostatic Forceps Revenue Share by Company (2021-2026) Table 7. Global Hemostatic Forceps Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Hemostatic Forceps Sales Volume Share by Company (2021-2026) Table 9. Global Hemostatic Forceps Average Price (USD/Unit) of Company (2021-2026) Table 10. Global Hemostatic Forceps Company Ranking, (2024-2026) & (USD Million) Table 11. Global Hemostatic Forceps Key Company Manufacturing Base & Headquarters Table 12. Global Hemostatic Forceps Company, Product Type & Application Table 13. Global Hemostatic Forceps Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Hemostatic Forceps by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Halstead Mosquito Hemostatic Forceps Table 18. Significant Companies of Kelly and Crile Hemostatic Forceps Table 19. Significant Companies of Rochester-Carmalt Hemostatic Forceps Table 20. Global Hemostatic Forceps Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Hemostatic Forceps Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Hemostatic Forceps Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Hemostatic Forceps Sales Volume Share by Type (2021-2026) Table 24. Global Hemostatic Forceps Sales Volume Share by Type (2027-2032) Table 25. Global Hemostatic Forceps Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Hemostatic Forceps Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Hemostatic Forceps Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Hemostatic Forceps Sales Value Share by Type (2021-2026) Table 29. Global Hemostatic Forceps Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Surgical Table 31. Significant Companies of Dissection Table 32. Significant Companies of Dental Table 33. Significant Companies of Laparoscopic Table 34. Significant Companies of Others Table 35. Global Hemostatic Forceps Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Hemostatic Forceps Sales Volume by Application (2021-2026) & (K Units) Table 37. Global Hemostatic Forceps Sales Volume by Application (2027-2032) & (K Units) Table 38. Global Hemostatic Forceps Sales Volume Share by Application (2021-2026) Table 39. Global Hemostatic Forceps Sales Volume Share by Application (2027-2032) Table 40. Global Hemostatic Forceps Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Hemostatic Forceps Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Hemostatic Forceps Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Hemostatic Forceps Sales Value Share by Application (2021-2026) Table 44. Global Hemostatic Forceps Sales Value Share by Application (2027-2032) Table 45. Global Hemostatic Forceps Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 46. Global Hemostatic Forceps Sales by Region (2021-2026) & (K Units) Table 47. Global Hemostatic Forceps Sales Market Share by Region (2021-2026) Table 48. Global Hemostatic Forceps Sales by Region (2027-2032) & (K Units) Table 49. Global Hemostatic Forceps Sales Market Share by Region (2027-2032) Table 50. Global Hemostatic Forceps Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Hemostatic Forceps Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Hemostatic Forceps Sales Value Share by Region (2021-2026) Table 53. Global Hemostatic Forceps Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Hemostatic Forceps Sales Value Share by Region (2027-2032) Table 55. Global Hemostatic Forceps Market Average Price (USD/Unit) by Region (2021-2026) Table 56. Global Hemostatic Forceps Market Average Price (USD/Unit) by Region (2027-2032) Table 57. Global Hemostatic Forceps Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Global Hemostatic Forceps Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Hemostatic Forceps Sales by Country (2021-2026) & (K Units) Table 60. Global Hemostatic Forceps Sales Market Share by Country (2021-2026) Table 61. Global Hemostatic Forceps Sales by Country (2027-2032) & (K Units) Table 62. Global Hemostatic Forceps Sales Market Share by Country (2027-2032) Table 63. Global Hemostatic Forceps Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Hemostatic Forceps Sales Value Market Share by Country (2021-2026) Table 65. Global Hemostatic Forceps Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Hemostatic Forceps Sales Value Market Share by Country (2027-2032) Table 67. Medline Company Information Table 68. Medline Business Overview Table 69. Medline Hemostatic Forceps Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 70. Medline Hemostatic Forceps Product Portfolio Table 71. Medline Recent Development Table 72. B. Braun Company Information Table 73. B. Braun Business Overview Table 74. B. Braun Hemostatic Forceps Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 75. B. Braun Hemostatic Forceps Product Portfolio Table 76. B. Braun Recent Development Table 77. CareFusion Company Information Table 78. CareFusion Business Overview Table 79. CareFusion Hemostatic Forceps Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 80. CareFusion Hemostatic Forceps Product Portfolio Table 81. CareFusion Recent Development Table 82. Asa Dental Company Information Table 83. Asa Dental Business Overview Table 84. Asa Dental Hemostatic Forceps Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 85. Asa Dental Hemostatic Forceps Product Portfolio Table 86. Asa Dental Recent Development Table 87. Sklar Company Information Table 88. Sklar Business Overview Table 89. Sklar Hemostatic Forceps Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 90. Sklar Hemostatic Forceps Product Portfolio Table 91. Sklar Recent Development Table 92. Scanlan International Company Information Table 93. Scanlan International Business Overview Table 94. Scanlan International Hemostatic Forceps Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 95. Scanlan International Hemostatic Forceps Product Portfolio Table 96. Scanlan International Recent Development Table 97. Shanghai Medical Instruments Company Information Table 98. Shanghai Medical Instruments Business Overview Table 99. Shanghai Medical Instruments Hemostatic Forceps Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 100. Shanghai Medical Instruments Hemostatic Forceps Product Portfolio Table 101. Shanghai Medical Instruments Recent Development Table 102. Lawton Company Information Table 103. Lawton Business Overview Table 104. Lawton Hemostatic Forceps Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 105. Lawton Hemostatic Forceps Product Portfolio Table 106. Lawton Recent Development Table 107. Hu-Friedy Company Information Table 108. Hu-Friedy Business Overview Table 109. Hu-Friedy Hemostatic Forceps Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 110. Hu-Friedy Hemostatic Forceps Product Portfolio Table 111. Hu-Friedy Recent Development Table 112. Xinhua Surgical Company Information Table 113. Xinhua Surgical Business Overview Table 114. Xinhua Surgical Hemostatic Forceps Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 115. Xinhua Surgical Hemostatic Forceps Product Portfolio Table 116. Xinhua Surgical Recent Development Table 117. Towne Brothers Company Information Table 118. Towne Brothers Business Overview Table 119. Towne Brothers Hemostatic Forceps Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 120. Towne Brothers Hemostatic Forceps Product Portfolio Table 121. Towne Brothers Recent Development Table 122. Teleflex Medical Company Information Table 123. Teleflex Medical Business Overview Table 124. Teleflex Medical Hemostatic Forceps Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 125. Teleflex Medical Hemostatic Forceps Product Portfolio Table 126. Teleflex Medical Recent Development Table 127. Delacroix Chevalier Company Information Table 128. Delacroix Chevalier Business Overview Table 129. Delacroix Chevalier Hemostatic Forceps Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 130. Delacroix Chevalier Hemostatic Forceps Product Portfolio Table 131. Delacroix Chevalier Recent Development Table 132. YDM Company Information Table 133. YDM Business Overview Table 134. YDM Hemostatic Forceps Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 135. YDM Hemostatic Forceps Product Portfolio Table 136. YDM Recent Development Table 137. M A Corporation Company Information Table 138. M A Corporation Business Overview Table 139. M A Corporation Hemostatic Forceps Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 140. M A Corporation Hemostatic Forceps Product Portfolio Table 141. M A Corporation Recent Development Table 142. MedGyn Products Company Information Table 143. MedGyn Products Business Overview Table 144. MedGyn Products Hemostatic Forceps Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 145. MedGyn Products Hemostatic Forceps Product Portfolio Table 146. MedGyn Products Recent Development Table 147. Inami Company Information Table 148. Inami Business Overview Table 149. Inami Hemostatic Forceps Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 150. Inami Hemostatic Forceps Product Portfolio Table 151. Inami Recent Development Table 152. Ted Pella Company Information Table 153. Ted Pella Business Overview Table 154. Ted Pella Hemostatic Forceps Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 155. Ted Pella Hemostatic Forceps Product Portfolio Table 156. Ted Pella Recent Development Table 157. Medicon eG Company Information Table 158. Medicon eG Business Overview Table 159. Medicon eG Hemostatic Forceps Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 160. Medicon eG Hemostatic Forceps Product Portfolio Table 161. Medicon eG Recent Development Table 162. J & J Instruments Company Information Table 163. J & J Instruments Business Overview Table 164. J & J Instruments Hemostatic Forceps Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 165. J & J Instruments Hemostatic Forceps Product Portfolio Table 166. J & J Instruments Recent Development Table 167. American Diagnostic Company Information Table 168. American Diagnostic Business Overview Table 169. American Diagnostic Hemostatic Forceps Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 170. American Diagnostic Hemostatic Forceps Product Portfolio Table 171. American Diagnostic Recent Development Table 172. Key Raw Materials Table 173. Raw Materials Key Suppliers Table 174. Hemostatic Forceps Distributors List Table 175. Hemostatic Forceps Customers List Table 176. Research Programs/Design for This Report Table 177. Authors List of This Report Table 178. Secondary Sources Table 179. Primary Sources List of Figures Figure 1. Hemostatic Forceps Product Image Figure 2. Global Hemostatic Forceps Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hemostatic Forceps Sales Value (2021-2032) & (US$ Million) Figure 4. Global Hemostatic Forceps Sales (2021-2032) & (K Units) Figure 5. Global Hemostatic Forceps Sales Average Price (USD/Unit) & (2021-2032) Figure 6. Global Hemostatic Forceps Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Halstead Mosquito Hemostatic Forceps Image Figure 10. Kelly and Crile Hemostatic Forceps Image Figure 11. Rochester-Carmalt Hemostatic Forceps Image Figure 12. Global Hemostatic Forceps Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Hemostatic Forceps Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Hemostatic Forceps Sales Volume Share by Type (2021-2032) Figure 15. Global Hemostatic Forceps Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Hemostatic Forceps Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Hemostatic Forceps Sales Value Share by Type (2021-2032) Figure 18. Surgical Image Figure 19. Dissection Image Figure 20. Dental Image Figure 21. Laparoscopic Image Figure 22. Others Image Figure 23. Global Hemostatic Forceps Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Hemostatic Forceps Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Hemostatic Forceps Sales Volume Share by Application (2021-2032) Figure 26. Global Hemostatic Forceps Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Hemostatic Forceps Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Hemostatic Forceps Sales Value Share by Application (2021-2032) Figure 29. Global Hemostatic Forceps Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 30. Global Hemostatic Forceps Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Hemostatic Forceps Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Hemostatic Forceps Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Hemostatic Forceps Sales Value (2021-2032) & (US$ Million) Figure 34. North America Hemostatic Forceps Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Hemostatic Forceps Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Hemostatic Forceps Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Hemostatic Forceps Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Hemostatic Forceps Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Hemostatic Forceps Sales Value (2021-2032) & (US$ Million) Figure 40. South America Hemostatic Forceps Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Hemostatic Forceps Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Hemostatic Forceps Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Hemostatic Forceps Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Hemostatic Forceps Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Hemostatic Forceps Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Hemostatic Forceps Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Hemostatic Forceps Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Hemostatic Forceps Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Hemostatic Forceps Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Hemostatic Forceps Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Hemostatic Forceps Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Hemostatic Forceps Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Hemostatic Forceps Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Hemostatic Forceps Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Hemostatic Forceps Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Hemostatic Forceps Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Hemostatic Forceps Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Hemostatic Forceps Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Hemostatic Forceps Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Hemostatic Forceps Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Hemostatic Forceps Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Hemostatic Forceps Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Hemostatic Forceps Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Hemostatic Forceps Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Hemostatic Forceps Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Hemostatic Forceps Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Hemostatic Forceps Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Hemostatic Forceps Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Hemostatic Forceps Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Hemostatic Forceps Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Hemostatic Forceps Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Hemostatic Forceps Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Hemostatic Forceps Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Hemostatic Forceps Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Hemostatic Forceps Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Hemostatic Forceps Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Hemostatic Forceps Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Hemostatic Forceps Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Hemostatic Forceps Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Hemostatic Forceps Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Hemostatic Forceps Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Hemostatic Forceps Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Hemostatic Forceps Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Hemostatic Forceps Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Hemostatic Forceps Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Hemostatic Forceps Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Hemostatic Forceps Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Hemostatic Forceps Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Hemostatic Forceps Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Hemostatic Forceps Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Hemostatic Forceps Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Hemostatic Forceps Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Hemostatic Forceps Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Hemostatic Forceps Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Hemostatic Forceps Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Hemostatic Forceps Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Hemostatic Forceps Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Hemostatic Forceps Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Hemostatic Forceps Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Hemostatic Forceps Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Hemostatic Forceps Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Hemostatic Forceps Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Hemostatic Forceps Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Hemostatic Forceps Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Hemostatic Forceps Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Hemostatic Forceps Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Hemostatic Forceps Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Hemostatic Forceps Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Hemostatic Forceps Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Hemostatic Forceps Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Hemostatic Forceps Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Hemostatic Forceps Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Hemostatic Forceps Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Hemostatic Forceps Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Hemostatic Forceps Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Hemostatic Forceps Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Hemostatic Forceps Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Hemostatic Forceps Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Hemostatic Forceps Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Hemostatic Forceps Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Hemostatic Forceps Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Hemostatic Forceps Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Hemostatic Forceps Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Hemostatic Forceps Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Hemostatic Forceps Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Hemostatic Forceps Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Hemostatic Forceps Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Hemostatic Forceps Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Halstead Mosquito Hemostatic Forceps
  • Kelly and Crile Hemostatic Forceps
  • Rochester-Carmalt Hemostatic Forceps
Applications
  • Surgical
  • Dissection
  • Dental
  • Laparoscopic
  • Others
Companies covered
  • Medline
  • B. Braun
  • CareFusion
  • Asa Dental
  • Sklar
  • Scanlan International
  • Shanghai Medical Instruments
  • Lawton
  • Hu-Friedy
  • Xinhua Surgical
  • Towne Brothers
  • Teleflex Medical
  • Delacroix Chevalier
  • YDM
  • M A Corporation
  • MedGyn Products
  • Inami
  • Ted Pella
  • Medicon eG
  • J & J Instruments
  • American Diagnostic

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Hemostatic Forceps Sales Value (2021-2032)
  4. 1.2.2 Global Hemostatic Forceps Sales Volume (2021-2032)
  5. 1.2.3 Global Hemostatic Forceps Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Hemostatic Forceps Market Dynamics
  1. 2.1 Hemostatic Forceps Industry Trends
  2. 2.2 Hemostatic Forceps Industry Drivers
  3. 2.3 Hemostatic Forceps Industry Opportunities and Challenges
  4. 2.4 Hemostatic Forceps Industry Restraints
3 Hemostatic Forceps Market by Company
  1. 3.1 Global Hemostatic Forceps Company Revenue Ranking in 2025
  2. 3.2 Global Hemostatic Forceps Revenue by Company (2021-2026)
  3. 3.3 Global Hemostatic Forceps Sales Volume by Company (2021-2026)
  4. 3.4 Global Hemostatic Forceps Average Price by Company (2021-2026)
  5. 3.5 Global Hemostatic Forceps Company Ranking (2024-2026)
  6. 3.6 Global Hemostatic Forceps Company Manufacturing Base and Headquarters
  7. 3.7 Global Hemostatic Forceps Company Product Type and Application
  8. 3.8 Global Hemostatic Forceps Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Hemostatic Forceps Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Hemostatic Forceps Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Hemostatic Forceps Market by Type
  1. 4.1 Hemostatic Forceps Type Introduction
  2. 4.1.1 Halstead Mosquito Hemostatic Forceps
  3. 4.1.2 Kelly and Crile Hemostatic Forceps
  4. 4.1.3 Rochester-Carmalt Hemostatic Forceps
  5. 4.2 Global Hemostatic Forceps Sales Volume by Type
  6. 4.2.1 Global Hemostatic Forceps Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Hemostatic Forceps Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Hemostatic Forceps Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Hemostatic Forceps Sales Value by Type
  10. 4.3.1 Global Hemostatic Forceps Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Hemostatic Forceps Sales Value by Type (2021-2032)
  12. 4.3.3 Global Hemostatic Forceps Sales Value Share by Type (2021-2032)
5 Hemostatic Forceps Market by Application
  1. 5.1 Hemostatic Forceps Application Introduction
  2. 5.1.1 Surgical
  3. 5.1.2 Dissection
  4. 5.1.3 Dental
  5. 5.1.4 Laparoscopic
  6. 5.1.5 Others
  7. 5.2 Global Hemostatic Forceps Sales Volume by Application
  8. 5.2.1 Global Hemostatic Forceps Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Hemostatic Forceps Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Hemostatic Forceps Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Hemostatic Forceps Sales Value by Application
  12. 5.3.1 Global Hemostatic Forceps Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Hemostatic Forceps Sales Value by Application (2021-2032)
  14. 5.3.3 Global Hemostatic Forceps Sales Value Share by Application (2021-2032)
6 Hemostatic Forceps Regional Sales and Value Analysis
  1. 6.1 Global Hemostatic Forceps Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Hemostatic Forceps Sales by Region (2021-2032)
  3. 6.2.1 Global Hemostatic Forceps Sales by Region: 2021-2026
  4. 6.2.2 Global Hemostatic Forceps Sales by Region (2027-2032)
  5. 6.3 Global Hemostatic Forceps Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Hemostatic Forceps Sales Value by Region (2021-2032)
  7. 6.4.1 Global Hemostatic Forceps Sales Value by Region: 2021-2026
  8. 6.4.2 Global Hemostatic Forceps Sales Value by Region (2027-2032)
  9. 6.5 Global Hemostatic Forceps Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Hemostatic Forceps Sales Value (2021-2032)
  12. 6.6.2 North America Hemostatic Forceps Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Hemostatic Forceps Sales Value (2021-2032)
  15. 6.7.2 Europe Hemostatic Forceps Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Hemostatic Forceps Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Hemostatic Forceps Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Hemostatic Forceps Sales Value (2021-2032)
  21. 6.9.2 South America Hemostatic Forceps Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Hemostatic Forceps Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Hemostatic Forceps Sales Value Share by Country, 2025 VS 2032
7 Hemostatic Forceps Country-level Sales and Value Analysis
  1. 7.1 Global Hemostatic Forceps Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Hemostatic Forceps Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Hemostatic Forceps Sales by Country (2021-2032)
  4. 7.3.1 Global Hemostatic Forceps Sales by Country (2021-2026)
  5. 7.3.2 Global Hemostatic Forceps Sales by Country (2027-2032)
  6. 7.4 Global Hemostatic Forceps Sales Value by Country (2021-2032)
  7. 7.4.1 Global Hemostatic Forceps Sales Value by Country (2021-2026)
  8. 7.4.2 Global Hemostatic Forceps Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Hemostatic Forceps Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Hemostatic Forceps Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Hemostatic Forceps Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Hemostatic Forceps Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Hemostatic Forceps Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Hemostatic Forceps Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Hemostatic Forceps Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Hemostatic Forceps Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Hemostatic Forceps Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Hemostatic Forceps Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Hemostatic Forceps Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Hemostatic Forceps Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Hemostatic Forceps Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Hemostatic Forceps Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Hemostatic Forceps Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Hemostatic Forceps Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Hemostatic Forceps Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Hemostatic Forceps Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Hemostatic Forceps Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Hemostatic Forceps Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Hemostatic Forceps Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Hemostatic Forceps Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Hemostatic Forceps Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Hemostatic Forceps Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Hemostatic Forceps Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Hemostatic Forceps Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Hemostatic Forceps Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Hemostatic Forceps Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Hemostatic Forceps Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Hemostatic Forceps Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Hemostatic Forceps Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Hemostatic Forceps Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Hemostatic Forceps Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Hemostatic Forceps Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Hemostatic Forceps Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Hemostatic Forceps Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Hemostatic Forceps Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Hemostatic Forceps Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Hemostatic Forceps Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Hemostatic Forceps Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Hemostatic Forceps Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Hemostatic Forceps Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Hemostatic Forceps Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Hemostatic Forceps Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Hemostatic Forceps Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Hemostatic Forceps Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Hemostatic Forceps Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Hemostatic Forceps Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Hemostatic Forceps Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Hemostatic Forceps Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Hemostatic Forceps Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Hemostatic Forceps Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Hemostatic Forceps Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Hemostatic Forceps Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Hemostatic Forceps Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Hemostatic Forceps Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Hemostatic Forceps Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Hemostatic Forceps Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Hemostatic Forceps Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Hemostatic Forceps Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Hemostatic Forceps Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Hemostatic Forceps Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Hemostatic Forceps Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Hemostatic Forceps Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Hemostatic Forceps Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Hemostatic Forceps Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Hemostatic Forceps Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Hemostatic Forceps Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Hemostatic Forceps Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Hemostatic Forceps Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Hemostatic Forceps Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Hemostatic Forceps Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Hemostatic Forceps Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Hemostatic Forceps Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Hemostatic Forceps Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Hemostatic Forceps Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Hemostatic Forceps Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Hemostatic Forceps Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Hemostatic Forceps Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Hemostatic Forceps Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Hemostatic Forceps Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Hemostatic Forceps Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Hemostatic Forceps Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Hemostatic Forceps Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Medline
  2. 8.1.1 Medline Company Information
  3. 8.1.2 Medline Business Overview
  4. 8.1.3 Medline Hemostatic Forceps Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Medline Hemostatic Forceps Product Portfolio
  6. 8.1.5 Medline Recent Developments
  7. 8.2 B. Braun
  8. 8.2.1 B. Braun Company Information
  9. 8.2.2 B. Braun Business Overview
  10. 8.2.3 B. Braun Hemostatic Forceps Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 B. Braun Hemostatic Forceps Product Portfolio
  12. 8.2.5 B. Braun Recent Developments
  13. 8.3 CareFusion
  14. 8.3.1 CareFusion Company Information
  15. 8.3.2 CareFusion Business Overview
  16. 8.3.3 CareFusion Hemostatic Forceps Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 CareFusion Hemostatic Forceps Product Portfolio
  18. 8.3.5 CareFusion Recent Developments
  19. 8.4 Asa Dental
  20. 8.4.1 Asa Dental Company Information
  21. 8.4.2 Asa Dental Business Overview
  22. 8.4.3 Asa Dental Hemostatic Forceps Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Asa Dental Hemostatic Forceps Product Portfolio
  24. 8.4.5 Asa Dental Recent Developments
  25. 8.5 Sklar
  26. 8.5.1 Sklar Company Information
  27. 8.5.2 Sklar Business Overview
  28. 8.5.3 Sklar Hemostatic Forceps Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Sklar Hemostatic Forceps Product Portfolio
  30. 8.5.5 Sklar Recent Developments
  31. 8.6 Scanlan International
  32. 8.6.1 Scanlan International Company Information
  33. 8.6.2 Scanlan International Business Overview
  34. 8.6.3 Scanlan International Hemostatic Forceps Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Scanlan International Hemostatic Forceps Product Portfolio
  36. 8.6.5 Scanlan International Recent Developments
  37. 8.7 Shanghai Medical Instruments
  38. 8.7.1 Shanghai Medical Instruments Company Information
  39. 8.7.2 Shanghai Medical Instruments Business Overview
  40. 8.7.3 Shanghai Medical Instruments Hemostatic Forceps Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Shanghai Medical Instruments Hemostatic Forceps Product Portfolio
  42. 8.7.5 Shanghai Medical Instruments Recent Developments
  43. 8.8 Lawton
  44. 8.8.1 Lawton Company Information
  45. 8.8.2 Lawton Business Overview
  46. 8.8.3 Lawton Hemostatic Forceps Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Lawton Hemostatic Forceps Product Portfolio
  48. 8.8.5 Lawton Recent Developments
  49. 8.9 Hu-Friedy
  50. 8.9.1 Hu-Friedy Company Information
  51. 8.9.2 Hu-Friedy Business Overview
  52. 8.9.3 Hu-Friedy Hemostatic Forceps Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Hu-Friedy Hemostatic Forceps Product Portfolio
  54. 8.9.5 Hu-Friedy Recent Developments
  55. 8.10 Xinhua Surgical
  56. 8.10.1 Xinhua Surgical Company Information
  57. 8.10.2 Xinhua Surgical Business Overview
  58. 8.10.3 Xinhua Surgical Hemostatic Forceps Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Xinhua Surgical Hemostatic Forceps Product Portfolio
  60. 8.10.5 Xinhua Surgical Recent Developments
  61. 8.11 Towne Brothers
  62. 8.11.1 Towne Brothers Company Information
  63. 8.11.2 Towne Brothers Business Overview
  64. 8.11.3 Towne Brothers Hemostatic Forceps Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Towne Brothers Hemostatic Forceps Product Portfolio
  66. 8.11.5 Towne Brothers Recent Developments
  67. 8.12 Teleflex Medical
  68. 8.12.1 Teleflex Medical Company Information
  69. 8.12.2 Teleflex Medical Business Overview
  70. 8.12.3 Teleflex Medical Hemostatic Forceps Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Teleflex Medical Hemostatic Forceps Product Portfolio
  72. 8.12.5 Teleflex Medical Recent Developments
  73. 8.13 Delacroix Chevalier
  74. 8.13.1 Delacroix Chevalier Company Information
  75. 8.13.2 Delacroix Chevalier Business Overview
  76. 8.13.3 Delacroix Chevalier Hemostatic Forceps Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Delacroix Chevalier Hemostatic Forceps Product Portfolio
  78. 8.13.5 Delacroix Chevalier Recent Developments
  79. 8.14 YDM
  80. 8.14.1 YDM Company Information
  81. 8.14.2 YDM Business Overview
  82. 8.14.3 YDM Hemostatic Forceps Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 YDM Hemostatic Forceps Product Portfolio
  84. 8.14.5 YDM Recent Developments
  85. 8.15 M A Corporation
  86. 8.15.1 M A Corporation Company Information
  87. 8.15.2 M A Corporation Business Overview
  88. 8.15.3 M A Corporation Hemostatic Forceps Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 M A Corporation Hemostatic Forceps Product Portfolio
  90. 8.15.5 M A Corporation Recent Developments
  91. 8.16 MedGyn Products
  92. 8.16.1 MedGyn Products Company Information
  93. 8.16.2 MedGyn Products Business Overview
  94. 8.16.3 MedGyn Products Hemostatic Forceps Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 MedGyn Products Hemostatic Forceps Product Portfolio
  96. 8.16.5 MedGyn Products Recent Developments
  97. 8.17 Inami
  98. 8.17.1 Inami Company Information
  99. 8.17.2 Inami Business Overview
  100. 8.17.3 Inami Hemostatic Forceps Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Inami Hemostatic Forceps Product Portfolio
  102. 8.17.5 Inami Recent Developments
  103. 8.18 Ted Pella
  104. 8.18.1 Ted Pella Company Information
  105. 8.18.2 Ted Pella Business Overview
  106. 8.18.3 Ted Pella Hemostatic Forceps Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Ted Pella Hemostatic Forceps Product Portfolio
  108. 8.18.5 Ted Pella Recent Developments
  109. 8.19 Medicon eG
  110. 8.19.1 Medicon eG Company Information
  111. 8.19.2 Medicon eG Business Overview
  112. 8.19.3 Medicon eG Hemostatic Forceps Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Medicon eG Hemostatic Forceps Product Portfolio
  114. 8.19.5 Medicon eG Recent Developments
  115. 8.20 J & J Instruments
  116. 8.20.1 J & J Instruments Company Information
  117. 8.20.2 J & J Instruments Business Overview
  118. 8.20.3 J & J Instruments Hemostatic Forceps Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 J & J Instruments Hemostatic Forceps Product Portfolio
  120. 8.20.5 J & J Instruments Recent Developments
  121. 8.21 American Diagnostic
  122. 8.21.1 American Diagnostic Company Information
  123. 8.21.2 American Diagnostic Business Overview
  124. 8.21.3 American Diagnostic Hemostatic Forceps Sales, Value and Gross Margin (2021-2026)
  125. 8.21.4 American Diagnostic Hemostatic Forceps Product Portfolio
  126. 8.21.5 American Diagnostic Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Hemostatic Forceps Value Chain Analysis
  2. 9.1.1 Hemostatic Forceps Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Hemostatic Forceps Sales Mode & Process
  6. 9.2 Hemostatic Forceps Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Hemostatic Forceps Distributors
  9. 9.2.3 Hemostatic Forceps Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst